한글목차

세계 면역조직화학 시장의 미래는 병원, 진단 실험실, 학술 및 연구기관 시장에서 유망합니다. 세계 면역조직화학 시장은 2025-2031년 5.4%의 연평균 복합 성장률(CAGR)로 2031년까지 약 42억 달러에 달할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 의료 전문가들의 디지털 파스퇴르학 채택 증가, 만성 질환의 유병률 증가, 선진국의 노인 인구 급증 등입니다.

• Lucintel의 예측에 따르면, 용도별로는 만성질환 유병률 증가로 인해 진단용이 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.
• 최종 사용 산업별로는 병원이 병원 내에서 진단 시술을 하는 경향이 강해짐에 따라 병원 및 진단실험실이 가장 큰 부문을 차지할 것으로 보입니다.
• 지역별로는 APAC 지역이 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상되는데, 이는 각국 정부가 의료 인프라 및 서비스에 많은 투자를 하고 있기 때문으로 분석됩니다.

면역조직화학 시장의 전략적 성장 기회

면역조직화학 시장은 기술 발전과 다양한 응용 분야 수요 증가로 인해 몇 가지 전략적 성장 기회를 제시하고 있습니다. 이러한 기회가 IHC 솔루션의 미래를 형성하고 있습니다.

• 종양 활용 영역의 확장: 암 진단 및 연구에 IHC를 사용하는 것은 큰 성장 잠재력을 가지고 있습니다. 향상된 바이오마커 검출과 새로운 분석법은 보다 정확한 암 진단과 맞춤 치료를 지원하고 있습니다.
• 자동화 솔루션 개발: 시장은 자동화된 IHC 염색 시스템 개발에 성장 기회를 제공합니다. 자동화는 실험실의 효율성과 일관성을 향상시키기 위해 투자 및 개발의 중요한 분야가 되었습니다.
• 디지털 병리학과의 통합: IHC를 디지털 병리학 솔루션과 통합하여 데이터 분석 및 해석을 강화하고 성장 기회를 창출합니다. 이러한 통합은 보다 효율적이고 정확한 진단과 연구를 지원합니다.
• 신흥 시장 집중: 신흥 시장 진출은 합리적인 가격의 지역밀착형 IHC 솔루션을 제공함으로써 성장의 기회를 제공합니다. 신흥 시장 진출은 현지의 니즈에 대응하고 시장 도달 범위를 확대할 수 있습니다.
• 개인 맞춤형 의료의 발전: 개인 맞춤형 의료에서 IHC의 적용이 확대되고 있으며, 개별 환자 프로파일에 맞는 분석법을 개발할 수 있는 기회가 있습니다. 이러한 추세는 보다 표적화되고 효과적인 치료를 지원할 수 있습니다.

이러한 성장 기회는 종양학, 자동화, 디지털 병리학, 신흥 시장, 개인 맞춤형 의료에 걸친 면역조직화학 시장의 확장 가능성을 강조합니다. 이러한 분야에 대한 자본 투자는 기술 혁신과 시장 성장을 가속할 수 있습니다.

면역조직화학 시장 성장 촉진요인 및 과제

면역조직화학 시장은 기술 발전, 경제적 요인, 규제 문제 등 다양한 시장 성장 촉진요인 및 과제에 영향을 받고 있습니다. 이러한 요인을 이해하는 것은 시장을 효과적으로 탐색하는 데 필수적입니다.

면역조직화학 시장을 이끄는 요인은 다음과 같습니다:

• 기술 발전: 멀티플렉스 분석 및 고해상도 이미징과 같은 IHC 기술 혁신이 시장 성장의 원동력이 되고 있습니다. 이러한 발전은 진단 능력을 향상시키고 응용 분야를 확대합니다.
• 암 발병률 증가: 전 세계적으로 암 발병률이 증가함에 따라 정확한 진단과 연구를 위한 첨단 IHC 솔루션에 대한 수요가 증가하고 있습니다. 이러한 수요 증가는 시장 확대를 뒷받침하고 있습니다.
• R&D 성장: R&D에 대한 투자가 증가하면서 IHC 제품 및 기술 혁신이 촉진되고 있습니다. 이러한 투자는 새로운 분석법과 솔루션의 개발을 촉진하고 있습니다.
• 검사실 자동화: 자동화된 IHC 염색 시스템 채택으로 검사실의 효율성과 일관성이 향상되었습니다. 자동화는 높은 처리량 환경을 지원하여 생산성을 향상시킵니다.
• 디지털 병리학과의 통합: IHC와 디지털 병리학 솔루션의 통합으로 데이터 분석 및 해석이 향상되어 진단 정확도와 연구 능력이 향상되고 있습니다.

면역조직화학 시장의 과제는 다음과 같습니다:

• 높은 개발 비용: 첨단 IHC 기술 개발에는 막대한 연구개발비가 소요됩니다. 이러한 높은 비용은 중소기업과 스타트업에게는 장벽이 될 수 있습니다.
• 규제 대응: IHC 제품에 대한 규제 요건을 충족하는 것은 특히 지역에 따라 어려울 수 있습니다. 시장 진입과 사업 운영을 위해서는 표준을 준수하는 것이 필수적입니다.
• 통합의 복잡성: 새로운 IHC 기술을 기존 시스템에 통합하는 것은 복잡할 수 있습니다. 호환성을 보장하고 원활한 운영을 위해서는 전문 지식과 세심한 계획이 필요합니다.
• 시장 경쟁: IHC 시장은 경쟁이 치열하고 많은 기업들이 유사한 제품을 제공합니다. 경쟁 우위를 점하기 위해서는 혁신과 성능으로 차별화를 꾀해야 합니다.
• 경제의 불확실성: 경기의 변동과 불확실성은 IHC 분야의 R&D 자금에 영향을 미칠 수 있습니다. 이러한 경제적 요인은 시장 성장과 투자에 영향을 미칠 수 있습니다.

면역조직화학 시장은 기술 발전, 암 발병률 증가, 자동화 등의 촉진요인에 의해 형성되는 반면, 높은 개발 비용과 규제 준수와 같은 과제에 직면해 있습니다. 이러한 시장 성장 촉진요인 및 과제를 해결하는 것은 시장의 성공과 성장에 매우 중요합니다.

목차

제1장 주요 요약

제2장 세계의 면역조직화학 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 촉진요인과 과제

제3장 시장 동향과 예측 분석(2019년-2031년)

• 거시경제 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 면역조직화학 시장 동향(2019-2024년)과 예측(2025-2031년)
• 세계의 면역조직화학 시장 : 제품별
  • 항체
  • 시약
  • 장비
  • 키트
• 세계의 면역조직화학 시장 : 용도별
  • 진단 용도
  • 연구 용도
  • 법의학 용도
• 세계의 면역조직화학 시장 : 최종 이용 산업별
  • 병원·진단실험실
  • 학술기관 및 연구기관
  • 기타 최종사용자

제4장 지역별 시장 동향과 예측 분석(2019년-2031년)

• 세계의 면역조직화학 시장 : 지역별
• 북미의 면역조직화학 시장
• 유럽의 면역조직화학 시장
• 아시아태평양의 면역조직화학 시장
• 기타 지역의 면역조직화학 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter의 Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 세계의 면역조직화학 시장 성장 기회 : 유형별
  • 세계의 면역조직화학 시장 성장 기회 : 용도별
  • 세계의 면역조직화학 시장 성장 기회 : 최종 이용 산업별
  • 세계의 면역조직화학 시장 성장 기회 : 지역별
• 세계 면역조직화학 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 면역조직화학 시장 생산능력 확대
  • 세계 면역조직화학 시장 기업인수합병(M&A), 합병사업
  • 인증 및 라이선싱

제7장 주요 기업 개요

• F.Hoffmann-LA-Roche
• Danaher
• Agilent Technologies
• Merck KGAA
• Bio-Rad Laboratories
• Eagle Biosciences
• Biocare Medical
• Elabscience Biotechnology
• Bio-Genex Laboratories
• Diagnostic Biosystem
• Histo-Line Laboratories

영문목차

The future of the global immunohistochemistry market looks promising with opportunities in the hospitals & diagnostic laboratory, and academic & research institute markets. The global immunohistochemistry market is expected to reach an estimated $4.2 billion by 2031 with a CAGR of 5.4% from 2025 to 2031. The major drivers for this market are the increasing adoption of digital pathology by healthcare professionals, the rising prevalence of chronic diseases, and the surge in the geriatric population in developed countries.

• Lucintel forecasts that, within the application category, diagnostic application is expected to witness the highest growth over the forecast period due to the rising incidence of chronic illnesses.
• Within the end use industry category, hospitals & diagnostic laboratories will remain the largest segment due to increasing trend of hospitals conducting diagnostic procedures in-house.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to government is making substantial investments in healthcare infrastructure and services.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Immunohistochemistry Market

The immunohistochemistry market is experiencing key trends driven by technological advancements and increasing demand for precise diagnostics. These trends are shaping the future of IHC applications and solutions.

• Multiplex IHC Assays: Multiplex assays enable the simultaneous detection of multiple biomarkers in a single sample. This trend enhances diagnostic accuracy and research capabilities by providing comprehensive data in one analysis.
• Automated Staining Systems: The adoption of automated IHC staining systems is increasing efficiency and consistency in laboratories. These systems reduce manual errors and improve reproducibility, making them crucial for high-throughput environments.
• AI and Machine Learning Integration: AI and machine learning are being integrated into IHC image analysis, enhancing the accuracy of biomarker detection and interpretation. These technologies enable more precise and faster data analysis.
• Enhanced Imaging Techniques: High-resolution imaging techniques are advancing, providing more detailed and accurate visualization of tissue samples. These techniques support better diagnostics and research outcomes by improving biomarker detection.
• Localized Solutions and Cost Reduction: There is a focus on developing localized IHC solutions to address regional needs and reduce costs. This trend aims to make IHC more accessible and affordable in emerging markets.

These trends are reshaping the immunohistochemistry market by improving diagnostic precision, efficiency, and accessibility. The focus on multiplex assays, automation, AI integration, enhanced imaging, and localized solutions is driving innovation and expanding the applications of IHC technologies.

Recent Developments in the Immunohistochemistry Market

Recent developments in the immunohistochemistry market highlight advancements in technology, automation, and regional growth. These developments are enhancing the capabilities and applications of IHC in diagnostics and research.

• Introduction of Multiplex IHC Assays: New multiplex IHC assays allow for the detection of multiple biomarkers simultaneously, improving diagnostic accuracy and research efficiency. This development supports a more comprehensive analysis of complex diseases.
• Advancement in Automated Staining Systems: Automation in IHC staining systems is increasing, with new systems offering higher throughput and consistency. These advancements reduce manual errors and streamline laboratory workflows.
• Integration of AI in Image Analysis: AI technologies are being incorporated into IHC image analysis, improving the accuracy of biomarker detection and data interpretation. This integration enhances research and diagnostic precision.
• Development of High-Resolution Imaging Techniques: High-resolution imaging techniques are advancing, providing more detailed visualization of tissue samples. This development supports better biomarker detection and enhances diagnostic capabilities.
• Expansion of Localized IHC Solutions: There is a growing focus on developing localized IHC solutions to meet regional needs and reduce costs. This expansion is making IHC more accessible in emerging markets.

These developments are advancing the immunohistochemistry market by enhancing diagnostic capabilities, improving efficiency, and expanding accessibility. Innovations in multiplex assays, automation, AI integration, high-resolution imaging, and localized solutions are driving progress in this field.

Strategic Growth Opportunities for Immunohistochemistry Market

The immunohistochemistry market presents several strategic growth opportunities driven by technological advancements and increasing demand across various applications. These opportunities are shaping the future of IHC solutions.

• Expansion in Oncology Applications: There is significant growth potential in using IHC for cancer diagnostics and research. Enhanced biomarker detection and new assays are supporting more accurate cancer diagnoses and personalized treatments.
• Development of Automated Solutions: The market offers growth opportunities in developing automated IHC staining systems. Automation improves laboratory efficiency and consistency, making it a key area for investment and development.
• Integration with Digital Pathology: Integrating IHC with digital pathology solutions creates growth opportunities by enhancing data analysis and interpretation. This integration supports more efficient and accurate diagnostics and research.
• Focus on Emerging Markets: Expanding into emerging markets presents growth opportunities by providing affordable and localized IHC solutions. This expansion addresses regional needs and increases market reach.
• Advancements in Personalized Medicine: The application of IHC in personalized medicine is growing, with opportunities to develop assays tailored to individual patient profiles. This trend supports more targeted and effective treatments.

These growth opportunities highlight the potential for expanding the immunohistochemistry market across oncology, automation, digital pathology, emerging markets, and personalized medicine. Capitalizing on these areas will drive innovation and market growth.

Immunohistochemistry Market Driver and Challenges

The immunohistochemistry market is influenced by various drivers and challenges, including technological advancements, economic factors, and regulatory issues. Understanding these factors is essential for navigating the market effectively.

The factors responsible for driving the immunohistochemistry market include:

• Technological Advancements: Innovations in IHC technology, such as multiplex assays and high-resolution imaging, are driving market growth. These advancements improve diagnostic capabilities and expand application areas.
• Increasing Cancer Incidence: The rising incidence of cancer globally is driving demand for advanced IHC solutions for accurate diagnostics and research. This growing need supports market expansion.
• Growth in Research and Development: Increased investment in research and development is fostering innovation in IHC products and technologies. This investment drives the development of new assays and solutions.
• Automation in Laboratories: The adoption of automated IHC staining systems is improving efficiency and consistency in laboratories. Automation supports high-throughput environments and enhances productivity.
• Integration with Digital Pathology: Integrating IHC with digital pathology solutions is advancing data analysis and interpretation, enhancing diagnostic accuracy and research capabilities.

Challenges in the immunohistochemistry market are:

• High Development Costs: Developing advanced IHC technologies involves significant research and development costs. These high costs can be a barrier for smaller companies and startups.
• Regulatory Compliance: Meeting regulatory requirements for IHC products, particularly in different regions, can be challenging. Ensuring compliance with standards is essential for market entry and operation.
• Complexity of Integration: Integrating new IHC technologies with existing systems can be complex. Ensuring compatibility and seamless operation requires expertise and careful planning.
• Market Competition: The IHC market is competitive, with numerous players offering similar products. Companies must differentiate themselves through innovation and performance to gain a competitive edge.
• Economic Uncertainties: Economic fluctuations and uncertainties can impact funding for research and development in the IHC sector. These economic factors can affect market growth and investment.

The immunohistochemistry market is shaped by drivers such as technological advancements, increasing cancer incidence, and automation, while facing challenges like high development costs and regulatory compliance. Addressing these drivers and challenges is crucial for success and growth in the market.

List of Immunohistochemistry Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, immunohistochemistry companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the immunohistochemistry companies profiled in this report include-

• F.Hoffmann-LA-Roche
• Danaher
• Agilent Technologies
• Merck KGAA
• Bio-Rad Laboratories
• Eagle Biosciences
• Biocare Medical
• Elabscience Biotechnology
• Bio-Genex Laboratories
• Diagnostic Biosystem

Immunohistochemistry by Segment

The study includes a forecast for the global immunohistochemistry market by product, application, end use industry, and region.

Immunohistochemistry Market by Product [Analysis by Value from 2019 to 2031]:

• Antibodies
• Reagents
• Equipment
• Kits

Immunohistochemistry Market by Application [Analysis by Value from 2019 to 2031]:

• Diagnostic Applications
• Research Applications
• Forensic Applications

Immunohistochemistry Market by End Use Industry [Analysis by Value from 2019 to 2031]:

• Hospitals & Diagnostic Laboratories
• Academic & Research Institutes
• Other End Users

Immunohistochemistry Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Immunohistochemistry Market

Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. Below are recent developments by major immunohistochemistry producers in key regions: the USA, China, India, Japan, and Germany.

• United States: In the U.S., significant advancements include the introduction of multiplex IHC assays that allow for simultaneous detection of multiple biomarkers. This development enhances diagnostic accuracy and research capabilities, particularly in oncology and neurology.
• China: China is focusing on improving the quality and cost-efficiency of IHC products. The country is seeing growth in domestic production of IHC reagents and antibodies, leading to increased availability and affordability of these tools for research and clinical applications.
• Germany: Germany is leading innovations in automated IHC staining systems, which enhance throughput and consistency in laboratories. These systems are becoming more sophisticated, incorporating artificial intelligence for better image analysis and data interpretation.
• India: India is witnessing increased adoption of IHC in diagnostic laboratories due to a rise in cancer cases. There is also a push towards developing localized IHC solutions to meet specific regional needs and improve healthcare accessibility.
• Japan: Japan is advancing in the development of high-resolution IHC imaging techniques. These techniques improve the detection and quantification of biomarkers, supporting more precise diagnostics and research in various disease areas.

Features of the Global Immunohistochemistry Market

Market Size Estimates: Immunohistochemistry market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Immunohistochemistry market size by various segments, such as by product, application, end use industry, and region in terms of value ($B).

Regional Analysis: Immunohistochemistry market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, applications, end use industries, and regions for the immunohistochemistry market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the immunohistochemistry market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the immunohistochemistry market by product (antibodies, reagents, equipment, and kits), application (diagnostic applications, research applications, and forensic applications), end use industry (hospitals & diagnostic laboratories, academic & research institutes, and other end users), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Immunohistochemistry Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Immunohistochemistry Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Immunohistochemistry Market by Product
  • 3.3.1: Antibodies
  • 3.3.2: Reagents
  • 3.3.3: Equipment
  • 3.3.4: Kits
• 3.4: Global Immunohistochemistry Market by Application
  • 3.4.1: Diagnostic Applications
  • 3.4.2: Research Applications
  • 3.4.3: Forensic Applications
• 3.5: Global Immunohistochemistry Market by End Use Industry
  • 3.5.1: Hospitals & Diagnostic Laboratories
  • 3.5.2: Academic & Research Institutes
  • 3.5.3: Other end users

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Immunohistochemistry Market by Region
• 4.2: North American Immunohistochemistry Market
  • 4.2.1: North American Market by Application: Diagnostic applications, Research applications, and Forensic applications
  • 4.2.2: North American Market by End Use Industry: Hospitals & Diagnostic Laboratories, Academic & research Institutes, and Other end users
• 4.3: European Immunohistochemistry Market
  • 4.3.1: European Market by Application: Diagnostic applications, Research applications, and Forensic applications
  • 4.3.2: European Market by End Use Industry: Hospitals & Diagnostic Laboratories, Academic & research Institutes, and Other end users
• 4.4: APAC Immunohistochemistry Market
  • 4.4.1: APAC Market by Application: Diagnostic applications, Research applications, and Forensic applications
  • 4.4.2: APAC Market by End Use Industry: Hospitals & Diagnostic Laboratories, Academic & research Institutes, and Other end users
• 4.5: ROW Immunohistochemistry Market
  • 4.5.1: ROW Market by Application: Diagnostic applications, Research applications, and Forensic applications
  • 4.5.2: ROW Market by End Use Industry: Hospitals & Diagnostic Laboratories, Academic & research Institutes, and Other end users

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Immunohistochemistry Market by Product
  • 6.1.2: Growth Opportunities for the Global Immunohistochemistry Market by Application
  • 6.1.3: Growth Opportunities for the Global Immunohistochemistry Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Immunohistochemistry Market by Region
• 6.2: Emerging Trends in the Global Immunohistochemistry Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Immunohistochemistry Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Immunohistochemistry Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: F.Hoffmann-LA-Roche
• 7.2: Danaher
• 7.3: Agilent Technologies
• 7.4: Merck KGAA
• 7.5: Bio-Rad Laboratories
• 7.6: Eagle Biosciences
• 7.7: Biocare Medical
• 7.8: Elabscience Biotechnology
• 7.9: Bio-Genex Laboratories
• 7.10: Diagnostic Biosystem
• 7.11: Histo-Line Laboratories